Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of chronic kidney disease in the US ...

Kidney disease, leading to kidney failure, afflicts disproportionately more black people than white people. Thus, there is a huge burden of kidney healthcare costs among black people all over the ...